Donor cell-derived myelofibrosis relapse after allogeneic stem cell transplantation

Haematologica. 2023 Jan 1;108(1):278-282. doi: 10.3324/haematol.2022.281564.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Graft vs Host Disease*
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Primary Myelofibrosis* / therapy
  • Recurrence
  • Tissue Donors
  • Transplantation Conditioning

Grants and funding

Funding: This study was supported by Associazione Italiana Ricerca sul Cancro (to AB).